Documentos de Académico
Documentos de Profesional
Documentos de Cultura
of
Cipla pharmaceuticals limited
LOGO
COMPANY PROFILE
Khwaja Abdul Hamied, the founder of Cipla, was born on October 31,
1898.
In 1935, he set up The Chemical, Industrial & Pharmaceutical
Laboratories, which came to be popularly known as Cipla.
On August 17, 1935, Cipla was registered as a public limited company
with an authorised capital of Rs 6 lakhs.
Cipla was officially opened on September 22, 1937 when the first
products were ready for the market.
July 4, 1939 was a red-letter day for Cipla, when the Father of the
Nation, Mahatma Gandhi, honoured the factory with a visit.
BOARD OF DIRECTORS
• Founder
• Dr. K.A. Hamied
(1898-1972)
• Chairman & Managing Director
• Dr. Y.K. Hamied
• Joint Managing Directors
• Mr. M.K. Hamied
Mr. Amar Lulla
• Non-Executive Directors
• Mr. V.C. Kotwal
Dr. H.R. Manchanda
Mr. S.A.A. Pinto
Mr. M.R. Raghavan
Mr. Ramesh Shroff
Mr. Pankaj Patel
PRODUCTS
• Back Alzheimer`s Dementia
• Amoebicides/Antiprotozoals
• Anabolic Steroids
• Analgesics/Antipyretics
• Anesthetic Agent
• Antacids/Antiflatulents
• Anthelmintics
• Anti-Arthritis
• Anti-Inflammatory Drugs
• Anti-TB Drugs
• Antiacne/Antipsoriatic Drugs
• Antiallergic Drugs
• Antibiotics/Antibacterials
• Anticancer Drugs
Anticoagulant and Antithrombotic Agents
Antidepressants
Antidiabetic
Antidiarrhoeals
Antiemetics
Antiepileptic
Antifungal
Antimalarials
Antimigraine Drugs
Antiobesity Drugs
Antiosteoporotic Agents
Antiparkinson's
Antipsychotic
Antipsychotic
Antiretroviral
Antispasmodics
Antiulcerants
Antivirals
Anxiolytics/Sedatives
Apetite Stimulants
Benign Prostatic Hyperplasia Drugs
Cardiovascular Agents
Cerebral Vasodialators
Cholestrol Reducers / Hypolipedemic Agents
Cough and Cold
Diuretics
Diuretics
Erectile Dysfunction Therapy
Expectorants/Cold Preparations/Mucolytes
Eye and Ear Preparations
Gout Preparations
Haematinic Preparation
Haemorrhoelogic Agents
Haemostatics
Hormone - Related Drugs
Hormone Replacement Therapy
Immunosuppressants
Iron Chelators
Irritable Bowel Syndrome
Laxatives
Motility Regulators
COMPETITORS
RANBAXY
NICHOLAS PIRAMAL
SUN PHARMA
NOVARTIS
PFIZER
REDDY LABS
AWARDS AND ACHIEVEMENTS
• Areas of Strength:
– Customer loyalty
– Dominant market share position
– Effectiveness of advertising
– Quality sales force
– Make and sell products of highest quality
– High integrity as a company
Analyzing Strengths and Weaknesses
• Areas of Strength:
– Excellence in product design and/or
performance
– Low-cost, high operating skill
– Leadership in product innovation
– Efficiency in customer service
– Personal relationships with customers
– Effectiveness in sales promotion
– Merchandising efficiency
Analyzing Strengths and Weaknesses
Areas of weaknesses:
• Inadequate definition of customer for product/market
development
• Ambiguous service policies
• Too many levels of reporting in the organizational setup
• Overlapping channels
• Lack of top management involvement in new product
development
• Lack of quantitative goals
Ratio Analysis
Liquidity Ratio’s.
1)CURRENT RATIO:
CURRENT ASSETS
CURRENT LIABILITIES
2005 2006 2007 2008
2)Proprietary Ratio
Fixed Assets
Net worth
Interpretation: The company’s inventory holding period in 2007 was 189 days
which was decreased to 166 days in year 2008.The company should
continue to decrease its inventory holding period in future also.
Working Capital TurnOver Ratio
CGS/Avg. Inventory
2)Operating Ratio
gross profit ratio:
Interpretation: The gross profit ratio has slightly decreased in 2008 when
compared to previous year because of increase in cost of goods sold
expenses.
Operating Ratio: